207 related articles for article (PubMed ID: 28342027)
21. The advantage of antibody cocktails for targeted alpha therapy depends on specific activity.
Pasternack JB; Domogauer JD; Khullar A; Akudugu JM; Howell RW
J Nucl Med; 2014 Dec; 55(12):2012-9. PubMed ID: 25349219
[TBL] [Abstract][Full Text] [Related]
22. A comparison of high- versus low-linear energy transfer somatostatin receptor targeted radionuclide therapy in vitro.
Nayak T; Norenberg J; Anderson T; Atcher R
Cancer Biother Radiopharm; 2005 Feb; 20(1):52-7. PubMed ID: 15778581
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of nitrogen-rich macrocyclic ligands for the chelation of therapeutic bismuth radioisotopes.
Wilson JJ; Ferrier M; Radchenko V; Maassen JR; Engle JW; Batista ER; Martin RL; Nortier FM; Fassbender ME; John KD; Birnbaum ER
Nucl Med Biol; 2015 May; 42(5):428-438. PubMed ID: 25684650
[TBL] [Abstract][Full Text] [Related]
24. Targeted alpha therapy: evidence for potential efficacy of alpha-immunoconjugates in the management of micrometastatic cancer.
Allen BJ
Australas Radiol; 1999 Nov; 43(4):480-6. PubMed ID: 10901964
[TBL] [Abstract][Full Text] [Related]
25. Targeted and Nontargeted α-Particle Therapies.
McDevitt MR; Sgouros G; Sofou S
Annu Rev Biomed Eng; 2018 Jun; 20():73-93. PubMed ID: 29345977
[TBL] [Abstract][Full Text] [Related]
26. The promise of targeted {alpha}-particle therapy.
Mulford DA; Scheinberg DA; Jurcic JG
J Nucl Med; 2005 Jan; 46 Suppl 1():199S-204S. PubMed ID: 15653670
[TBL] [Abstract][Full Text] [Related]
27. Ac-225 and her daughters: the many faces of Shiva.
McDevitt MR; Scheinberg DA
Cell Death Differ; 2002 Jun; 9(6):593-4. PubMed ID: 12032666
[No Abstract] [Full Text] [Related]
28. Radionuclides for radioimmunotherapy: criteria for selection.
Geerlings MW
Int J Biol Markers; 1993; 8(3):180-6. PubMed ID: 8277210
[TBL] [Abstract][Full Text] [Related]
29. Potential and pitfalls of therapy with alpha-particles.
Welch MJ
J Nucl Med; 2005 Aug; 46(8):1254-5. PubMed ID: 16085579
[No Abstract] [Full Text] [Related]
30. Targeted alpha therapy for cancer.
Allen BJ; Raja C; Rizvi S; Li Y; Tsui W; Zhang D; Song E; Qu CF; Kearsley J; Graham P; Thompson J
Phys Med Biol; 2004 Aug; 49(16):3703-12. PubMed ID: 15446799
[TBL] [Abstract][Full Text] [Related]
31.
Li M; Sagastume EA; Lee D; McAlister D; DeGraffenreid AJ; Olewine KR; Graves S; Copping R; Mirzadeh S; Zimmerman BE; Larsen RH; Johnson FL; Schultz MK
Curr Med Chem; 2020; 27(41):7003-7031. PubMed ID: 32720598
[TBL] [Abstract][Full Text] [Related]
32. Targeted Alpha Therapy: Current Clinical Applications.
Guerra Liberal FDC; O'Sullivan JM; McMahon SJ; Prise KM
Cancer Biother Radiopharm; 2020 Aug; 35(6):404-417. PubMed ID: 32552031
[TBL] [Abstract][Full Text] [Related]
33. Innovation, Impact, and Strategic Importance of Alpha-Emitting Radionuclides.
Mirzadeh S
J Med Imaging Radiat Sci; 2019 Dec; 50(4 Suppl 1):S21-S25. PubMed ID: 31420270
[TBL] [Abstract][Full Text] [Related]
34. Targeted Radiotherapy with Alpha-Particle Emitting Radionuclides Seminar, November 18, 2004, Cracow, Poland.
Zalutsky MR; Petelenz B
Nucl Med Rev Cent East Eur; 2004; 7(2):195. PubMed ID: 15968616
[No Abstract] [Full Text] [Related]
35. Alpha-particle-emitting radioisotopes coupled to antibody for acute myeloid leukaemia treatment.
Featherstone C
Mol Med Today; 1997 Jun; 3(6):232-3. PubMed ID: 9211409
[No Abstract] [Full Text] [Related]
36.
Sathekge M; Knoesen O; Meckel M; Modiselle M; Vorster M; Marx S
Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):1099-1100. PubMed ID: 28255795
[No Abstract] [Full Text] [Related]
37. NorthStar Perspectives for Actinium-225 Production at Commercial Scale.
Harvey JT
Curr Radiopharm; 2018; 11(3):180-191. PubMed ID: 29766832
[TBL] [Abstract][Full Text] [Related]
38. Targeted α-Therapy.
Brechbiel MW
Cancer Biother Radiopharm; 2020 Aug; 35(6):397. PubMed ID: 32503377
[No Abstract] [Full Text] [Related]
39. Targeted alpha therapy: a critical review of translational dosimetry research with emphasis on actinium-225.
Castillo Seoane D; de Saint-Hubert M; Crabbe M; Struelens L; Koole M
Q J Nucl Med Mol Imaging; 2020 Sep; 64(3):265-277. PubMed ID: 32441067
[TBL] [Abstract][Full Text] [Related]
40. Rapid preparation of short-lived alpha particle emitting radioimmunopharmaceuticals.
Ma D; McDevitt MR; Finn RD; Scheinberg DA
Appl Radiat Isot; 2001 Oct; 55(4):463-70. PubMed ID: 11545498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]